Zhou XJ - Search Results

1

Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.

Vaziri ND, Zhou XJ. Vaziri ND, et al. Among authors: zhou xj. Nephrol Dial Transplant. 2009 Apr;24(4):1082-8. doi: 10.1093/ndt/gfn601. Epub 2008 Nov 5. Nephrol Dial Transplant. 2009. PMID: 18987263 No abstract available.

2

Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.

Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Van Buren P, et al. Among authors: zhou xj. Int Urol Nephrol. 2012 Apr;44(2):499-507. doi: 10.1007/s11255-011-0028-5. Epub 2011 Jul 10. Int Urol Nephrol. 2012. PMID: 21744260 Free PMC article. Review.

3

Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats.

Augustyniak RA, Picken MM, Leonard D, Zhou XJ, Zhang W, Victor RG. Augustyniak RA, et al. Among authors: zhou xj. Clin Exp Pharmacol Physiol. 2010 Jan;37(1):12-8. doi: 10.1111/j.1440-1681.2009.05253.x. Epub 2009 Jun 29. Clin Exp Pharmacol Physiol. 2010. PMID: 19566818 Free PMC article.

4

Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury.

Wang S, Qin L, Wu T, Deng B, Sun Y, Hu D, Mohan C, Zhou XJ, Peng A. Wang S, et al. Among authors: zhou xj. Med Sci Monit. 2014 Oct 25;20:2043-53. doi: 10.12659/MSM.890909. Med Sci Monit. 2014. PMID: 25344353 Free PMC article.

5

The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis.

Peng A, Ye T, Rakheja D, Tu Y, Wang T, Du Y, Zhou JK, Vaziri ND, Hu Z, Mohan C, Zhou XJ. Peng A, et al. Among authors: zhou xj, zhou jk. Kidney Int. 2011 Sep;80(6):601-11. doi: 10.1038/ki.2011.121. Epub 2011 May 4. Kidney Int. 2011. PMID: 21544063

6

Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability.

Peng A, Wu T, Zeng C, Rakheja D, Zhu J, Ye T, Hutcheson J, Vaziri ND, Liu Z, Mohan C, Zhou XJ. Peng A, et al. Among authors: zhou xj. PLoS One. 2011;6(8):e23268. doi: 10.1371/journal.pone.0023268. Epub 2011 Aug 9. PLoS One. 2011. PMID: 21858050 Free PMC article.

7

Computational Analysis of High-Dimensional DNA Methylation Data for Cancer Prognosis.

Hu R, Zhou XJ, Li W. Hu R, et al. Among authors: zhou xj. J Comput Biol. 2022 Jun 6. doi: 10.1089/cmb.2022.0002. Online ahead of print. J Comput Biol. 2022. PMID: 35671506

8

Gradient-echo-train-based sub-millisecond periodic event encoded dynamic imaging with random (k, t)-space undersampling: k-t get-SPEEDI.

Luo Q, Zhong Z, Sun K, Scotti A, Zhou XJ. Luo Q, et al. Among authors: zhou xj. Magn Reson Med. 2022 Jun 6. doi: 10.1002/mrm.29313. Online ahead of print. Magn Reson Med. 2022. PMID: 35666824

9

Naringin suppressed airway inflammation and ameliorated pulmonary endothelial hyperpermeability by upregulating Aquaporin1 in lipopolysaccharide/cigarette smoke-induced mice.

Zhang HH, Zhou XJ, Zhong YS, Ji LT, Yu WY, Fang J, Ying HZ, Li CY. Zhang HH, et al. Among authors: zhou xj. Biomed Pharmacother. 2022 Jun;150:113035. doi: 10.1016/j.biopha.2022.113035. Epub 2022 Apr 28. Biomed Pharmacother. 2022. PMID: 35658207 Free article.

10

miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis.

Wang YC, Lu S, Zhou XJ, Yang L, Liu P, Zhang L, Hu Y, Dong XZ. Wang YC, et al. Among authors: zhou xj. Open Med (Wars). 2022 May 16;17(1):930-946. doi: 10.1515/med-2022-0486. eCollection 2022. Open Med (Wars). 2022. PMID: 35647303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results